- Home
- ADNT vs MANE Comparison
ADNT vs MANE Comparison
Compare ADNT & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADNT | MANE |
|---|---|---|
| Founded | 2016 | 2019 |
| Country | Ireland | United States |
| Employees | 65000 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADNT | MANE |
|---|---|---|
| Price | $20.91 | $99.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $25.41 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 845.6K | 689.9K |
| Earning Date | 05-06-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $17,439,000,000.00 | N/A |
| Revenue This Year | $2.71 | N/A |
| Revenue Next Year | $2.36 | N/A |
| P/E Ratio | $374.83 | ★ N/A |
| Revenue Growth | ★ 7.56 | N/A |
| 52 Week Low | $14.87 | $36.26 |
| 52 Week High | $27.32 | $117.71 |
Technical Indicators
Market Signals| Indicator | ADNT | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 44.93 | 56.31 |
| Support Level | $20.23 | $54.23 |
| Resistance Level | $21.76 | $117.71 |
| Average True Range (ATR) | 0.95 | 9.20 |
| MACD | -0.00 | -1.25 |
| Stochastic Oscillator | 22.41 | 26.26 |
Price Performance
Historical ComparisonAbout ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.